MDS Pharma Services Names Teresa Winslow and James Miskel to Senior Team
01 Aprile 2008 - 5:00PM
PR Newswire (US)
Experienced leaders will strengthen sales and strategy functions
KING OF PRUSSIA, PA, April 1 /PRNewswire-FirstCall/ -- MDS Pharma
Services, a leading provider of innovative drug discovery and
development solutions, has hired Teresa F. Winslow as Senior Vice
President -- Global Business Development and James Miskel as Vice
President -- Strategy and Corporate Development. To improve the
business' growth profile, Ms. Winslow will direct global business
development efforts and Mr. Miskel will focus on strategic
partnerships. "I'm delighted to add these two experienced leaders
to our senior management team," said MDS Pharma Services President
David Spaight. "Their skills and knowledge will allow us to seize
emerging opportunities to accelerate the growth of our business."
Ms. Winslow is an experienced executive leader of business
development in the healthcare industry. She was previously
President -- Dendrite Americas and Senior Vice President --
Dendrite International, a leading supplier of sales force and
marketing effectiveness solutions for the pharmaceutical industry.
Ms. Winslow oversaw all operations, sales and marketing functions
and led double-digit growth of the company's largest division. A
pharmacist by training, she earned a BS in Pharmacy from the
University of the Sciences in Philadelphia. Mr. Miskel joined MDS
from Wyeth Pharmaceuticals, where he was Assistant Vice President
for Business Planning & Strategy. He spent much of his career
with McKinsey & Company, leading growth strategy, operational
improvement, and acquisition work in the Americas and Europe for
leading pharmaceutical and medical device companies. He holds an
MBA from the Wharton School and an MA in International Studies from
the Lauder Institute, both of the University of Pennsylvania, and
originally trained as an aeronautical engineer, earning MS and BS
degrees from the Massachusetts Institute of Technology. About MDS
Pharma Services MDS Pharma Services is committed to delivering
quality service on-time. We offer a full spectrum of resources to
meet the drug discovery and development needs of the pharmaceutical
and biotechnology industries. With numerous facilities
strategically located around the world, we apply advanced
scientific and technological expertise throughout the drug
discovery and development process - from lead optimization, pre-IND
research, early clinical research (bioequivalence, phases I-IIa)
and bioanalysis through to global clinical development (phases
IIb-IV), central lab and centralized cardiac services. For more
information, visit our website at http://www.mdsps.com/. MDS Pharma
Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a
global life sciences company that provides market-leading products
and services that our customers need for the development of drugs
and diagnosis and treatment of disease. We are a leading global
provider of pharmaceutical contract research, medical isotopes for
molecular imaging, radiotherapeutics, and analytical instruments.
MDS has more than 5,500 highly skilled people in 29 countries. Find
out more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24
hours a day. DATASOURCE: MDS Pharma Services CONTACT: For
Investors: Kim Lee, (416) 675-6777 ext. 32606, ; For Media:
Charlene McGrady, (610) 239-7900 ext. 231,
Copyright